Tag: Pharmaceutical industry

news-05082024-200726

Analyst Ratings Update: Adaptimmune Therapeutics (NASDAQ: ADAP)

Adaptimmune Therapeutics, a clinical-stage biopharmaceutical company, has recently garnered the attention of analysts, with a mix of bullish and bearish sentiments. In the past...
news-23072024-234434

Sale of APEIRON Biologics AG Shares to American Investor: Baker McKenzie Advises Shareholders

Baker McKenzie recently provided legal advice to a large group of shareholders, consisting of over 90 individuals, regarding the sale of their shares in...
news-13072024-025623

CervoMed KOL Event: Neflamapimod for DLB – Expert Analysis | TipRanks

CervoMed is holding an important event with key opinion leaders to discuss a potential new treatment for dementia with Lewy bodies (DLB). The event...

The Crucial Role of Recognised Consulting Companies in Optimising Clinical Trials for the Pharmaceutical...

Clinical trials are the backbone of medical advancements, but they come at a steep price. The average cost of bringing a new drug to...
news-15062024-170815

AI-powered Feasibility Software by Lokavant for Optimizing Trials

Lokavant, a US-based clinical trial software company, has recently launched Spectrum, a new feasibility software solution powered by artificial intelligence (AI). This innovative software...
antibiotic-innovation-is-ailing-brain-drain-may-kill-it

Antibiotic innovation is ailing. ‘Brain drain’ may kill it

Antibiotic Crisis: The Looming Threat to Public HealthIn today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly...